Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 11 | 2019 | 93 | 2.100 |
Why?
|
| Arthroplasty, Replacement, Hip | 14 | 2019 | 135 | 2.080 |
Why?
|
| Prosthesis Failure | 10 | 2019 | 111 | 1.970 |
Why?
|
| Hip Prosthesis | 8 | 2019 | 116 | 1.390 |
Why?
|
| Prosthesis-Related Infections | 8 | 2020 | 46 | 1.290 |
Why?
|
| Acetabulum | 5 | 2020 | 53 | 1.280 |
Why?
|
| Reoperation | 16 | 2020 | 146 | 0.950 |
Why?
|
| Femur | 5 | 2019 | 134 | 0.910 |
Why?
|
| Hip Joint | 6 | 2020 | 88 | 0.850 |
Why?
|
| Knee Prosthesis | 4 | 2013 | 35 | 0.830 |
Why?
|
| Arthritis, Infectious | 3 | 2020 | 10 | 0.830 |
Why?
|
| Knee Joint | 5 | 2013 | 118 | 0.780 |
Why?
|
| Prosthesis Design | 5 | 2019 | 91 | 0.780 |
Why?
|
| Osteolysis | 3 | 2010 | 46 | 0.760 |
Why?
|
| Humans | 30 | 2020 | 5837 | 0.740 |
Why?
|
| Tibia | 3 | 2013 | 60 | 0.680 |
Why?
|
| Joint Diseases | 3 | 2012 | 20 | 0.660 |
Why?
|
| Periprosthetic Fractures | 3 | 2016 | 10 | 0.620 |
Why?
|
| Pain, Postoperative | 2 | 2019 | 66 | 0.590 |
Why?
|
| Aged | 17 | 2019 | 1860 | 0.560 |
Why?
|
| Bone Cements | 3 | 2020 | 18 | 0.550 |
Why?
|
| Male | 18 | 2019 | 3399 | 0.520 |
Why?
|
| Female | 18 | 2019 | 3346 | 0.520 |
Why?
|
| Bone Resorption | 2 | 2014 | 33 | 0.470 |
Why?
|
| Radiography | 5 | 2019 | 129 | 0.450 |
Why?
|
| Middle Aged | 16 | 2016 | 1775 | 0.440 |
Why?
|
| Postoperative Complications | 6 | 2014 | 154 | 0.430 |
Why?
|
| Aged, 80 and over | 12 | 2016 | 1034 | 0.400 |
Why?
|
| Retrospective Studies | 10 | 2014 | 584 | 0.380 |
Why?
|
| Pelvic Bones | 1 | 2012 | 5 | 0.380 |
Why?
|
| Treatment Outcome | 11 | 2016 | 601 | 0.360 |
Why?
|
| Polymethyl Methacrylate | 1 | 2011 | 2 | 0.330 |
Why?
|
| Metals | 1 | 2010 | 25 | 0.320 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 333 | 0.320 |
Why?
|
| Prostheses and Implants | 1 | 2010 | 71 | 0.310 |
Why?
|
| Patient Discharge | 1 | 2009 | 44 | 0.290 |
Why?
|
| Adult | 10 | 2016 | 1670 | 0.280 |
Why?
|
| Risk Factors | 5 | 2019 | 499 | 0.270 |
Why?
|
| Coated Materials, Biocompatible | 2 | 2005 | 17 | 0.270 |
Why?
|
| Demography | 1 | 2006 | 14 | 0.240 |
Why?
|
| Arthroplasty, Replacement | 1 | 2006 | 23 | 0.230 |
Why?
|
| Decision Support Techniques | 1 | 2005 | 7 | 0.220 |
Why?
|
| Hip Dislocation | 2 | 2016 | 11 | 0.210 |
Why?
|
| Odds Ratio | 2 | 2019 | 60 | 0.170 |
Why?
|
| Synovial Fluid | 4 | 2016 | 27 | 0.170 |
Why?
|
| C-Reactive Protein | 4 | 2016 | 27 | 0.170 |
Why?
|
| Osteotomy | 2 | 2014 | 26 | 0.170 |
Why?
|
| Tantalum | 2 | 2012 | 6 | 0.160 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2019 | 3 | 0.150 |
Why?
|
| Physical Examination | 1 | 2019 | 21 | 0.150 |
Why?
|
| Treatment Failure | 1 | 2019 | 24 | 0.150 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 62 | 0.150 |
Why?
|
| Incidence | 2 | 2013 | 165 | 0.150 |
Why?
|
| Osteoarthritis, Knee | 2 | 2014 | 88 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 109 | 0.140 |
Why?
|
| Osseointegration | 2 | 2016 | 46 | 0.130 |
Why?
|
| Povidone-Iodine | 2 | 2019 | 5 | 0.120 |
Why?
|
| Metal-on-Metal Joint Prostheses | 1 | 2015 | 9 | 0.110 |
Why?
|
| Intraoperative Complications | 2 | 2013 | 12 | 0.110 |
Why?
|
| Blood Sedimentation | 4 | 2016 | 14 | 0.110 |
Why?
|
| Prospective Studies | 3 | 2012 | 411 | 0.100 |
Why?
|
| Observer Variation | 1 | 2014 | 16 | 0.100 |
Why?
|
| Arthroplasty | 1 | 2014 | 21 | 0.100 |
Why?
|
| Porosity | 2 | 2010 | 24 | 0.100 |
Why?
|
| Disease Management | 1 | 2013 | 32 | 0.090 |
Why?
|
| Biomechanical Phenomena | 2 | 2016 | 156 | 0.090 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 23 | 0.090 |
Why?
|
| Recovery of Function | 2 | 2010 | 64 | 0.090 |
Why?
|
| United States | 3 | 2016 | 502 | 0.090 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2011 | 11 | 0.080 |
Why?
|
| Leukocyte Count | 3 | 2016 | 19 | 0.080 |
Why?
|
| Prevalence | 1 | 2011 | 72 | 0.080 |
Why?
|
| Algorithms | 2 | 2014 | 82 | 0.080 |
Why?
|
| Time Factors | 4 | 2016 | 374 | 0.080 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2011 | 51 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2009 | 52 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2009 | 24 | 0.070 |
Why?
|
| Therapeutic Irrigation | 2 | 2019 | 14 | 0.060 |
Why?
|
| Decision Making | 1 | 2006 | 49 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2005 | 136 | 0.060 |
Why?
|
| Osteogenesis | 1 | 2005 | 77 | 0.060 |
Why?
|
| Decision Trees | 1 | 2005 | 3 | 0.060 |
Why?
|
| Markov Chains | 1 | 2005 | 10 | 0.060 |
Why?
|
| ROC Curve | 2 | 2016 | 34 | 0.060 |
Why?
|
| Bone Diseases | 1 | 2005 | 4 | 0.050 |
Why?
|
| Device Removal | 1 | 2005 | 9 | 0.050 |
Why?
|
| Health Status Indicators | 1 | 2005 | 17 | 0.050 |
Why?
|
| Logistic Models | 2 | 2016 | 109 | 0.050 |
Why?
|
| Quality of Life | 1 | 2005 | 108 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 125 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2016 | 35 | 0.050 |
Why?
|
| Biomarkers | 2 | 2014 | 141 | 0.050 |
Why?
|
| Osteoarthritis | 1 | 2003 | 114 | 0.040 |
Why?
|
| Sex Factors | 2 | 2012 | 129 | 0.030 |
Why?
|
| Neutrophils | 1 | 2016 | 31 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 32 | 0.030 |
Why?
|
| Corrosion | 1 | 2015 | 22 | 0.030 |
Why?
|
| Operative Time | 1 | 2014 | 17 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2014 | 19 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2014 | 13 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 100 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 163 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 187 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 9 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 138 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 112 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 181 | 0.020 |
Why?
|
| Wound Closure Techniques | 1 | 2011 | 4 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 47 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 406 | 0.020 |
Why?
|
| Analgesia | 1 | 2010 | 15 | 0.020 |
Why?
|
| Length of Stay | 1 | 2010 | 45 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2010 | 112 | 0.020 |
Why?
|
| Chicago | 1 | 2010 | 239 | 0.020 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2008 | 21 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2008 | 30 | 0.020 |
Why?
|
| Walking | 1 | 2008 | 53 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2007 | 5 | 0.020 |
Why?
|
| Materials Testing | 1 | 2007 | 42 | 0.020 |
Why?
|
| Geography | 1 | 2003 | 5 | 0.010 |
Why?
|
| Animals | 1 | 2007 | 1349 | 0.010 |
Why?
|
| Medicare | 1 | 2003 | 30 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2003 | 22 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 60 | 0.010 |
Why?
|